Senores Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 29th Oct'26
Senores Pharmaceuticals Ltd 路 Intimation 路 23 Oct 2026, 11:42 pm
Senores Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 29th Oct'26 Senores Pharmaceuticals Limited has rescheduled its earnings conference call to discuss Q2 and H1 FY27 financial results. The call, hosted by DAM Capital Advisors Ltd, will now take place at 16:00 hrs IST on 29th Oct'26, advanced from the earlier scheduled time of 17:00 hrs IST. Senior management participants include Promoter & MD Swapnil Shah, Chairman Sanjay Majmudar, and Whole Time Director & CFO Deval Shah. The company confirmed that audio recordings and call transcripts will be made available on its website post-call.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
